| Microsite |
Includes videos, news releases, backgrounders, photos and more related to medical isotope supply:
nordion.com/isotopes |
| Media Contact |
| Shelley Maclean, Nordion: 613.592.3400, ext. 2414, E-mail: shelley.maclean@nordion.com |
| |
| News Releases |
| Mar 28, 2011:
Nordion Reports TheraSphere® Phase II Clinical Trial Results at Society of Interventional Radiology |
| Mar 23, 2011:
Nordion announces Phase III clinical trial to evaluate TheraSphere® in treatment
of unresectable hepatocellular carcinoma |
| Mar 23, 2011:
Nordion announces Phase III clinical trial to evaluate TheraSphere® for
liver metastases in colorectal cancer patients |
| Feb 5, 2010: MDS Nordion's TheraSphere for Unresectable Liver Cancer (HCC) Now Covered by Two Large U.S. Insurers |
| Mar 9, 2009: MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians |
| Jan. 10, 2007: Expanded use for TheraSphere offers physicians an innovative alternative to traditional liver cancer therapies |
| Video Animation |
| -
TheraSphere |
wmv (10.0 MB) |
| Media Contact |
| Shelley Maclean, Nordion: 613.592.3400, ext. 2414, E-mail: shelley.maclean@nordion.com |
